Navigation Links
Positive Xeloda(R) Five-Year Overall Survival Study Data in the Adjuvant Treatment of Colon Cancer Presented at Leading European Cancer Meeting
Date:9/25/2007

BARCELONA, Spain, Sept. 25 /PRNewswire/ -- Five-year follow-up overall survival data from the X-ACT (Xeloda in Adjuvant Colon Cancer Trial) study show that oral chemotherapy Xeloda(R) (capecitabine) is as effective as the current standard treatment - intravenous bolus 5-FU/LV (5-fluorouracil/ leucovorin) - in the adjuvant treatment of Dukes' C colon cancer. These data were presented today at the 14th European Cancer Conference (ECCO) in Barcelona, Spain.

Results show five-year overall survival rates for Xeloda at 71.4 percent compared to 68.4 percent in the 5-FU/LV arm. Additional data presented at the meeting from a previous analysis show that Xeloda is also comparable to 5- FU/LV with respect to disease-free survival (DFS) and relapse-free survival (RFS).

"These updated five-year overall survival data provide further proof that Xeloda can be a safe and effective alternative to the current standard of care for adjuvant colorectal cancer, which can require upwards of 30 clinic visits over the 24-week treatment course," said Dr. Howard Burris of the Sarah Cannon Research Institute, Nashville, Tenn., and lead U.S. investigator in the study. "Based on this evidence, physicians - especially those who have relied on 5- FU/LV - should feel confident about exploring Xeloda as a treatment option with their patients who could benefit from the flexibility of oral chemotherapy."

Previous results from the X-ACT study also show that Xeloda is more cost- effective than the Mayo Clinic regimen (the current standard treatment) and is associated with fewer side effects. Additionally, many of the side effects can be easily managed by altering the dose without compromising efficacy.(1,2) In the same analysis, costs for medicines to treat side effects, such as nausea and diarrhea, were cut by nearly 75 percent in the Xeloda arm compared to use of intravenous 5-FU/LV.

"We are pleased to see that Xeloda is standing up to its initial promise as an alternativ
'/>"/>

SOURCE Roche
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
2. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Protox Announces Positive Clinical Data from Prostate Cancer Study
5. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
6. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
7. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
8. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)...  Mark Farrah Associates (MFA), www.markfarrah.com , ... in their recent analysis brief.  According to the ... Medicare Advantage plans as of March 2015, an ... 54.3 million people are eligible for Medicare, according ... (CMS), with an unpenetrated market of 37 million ...
(Date:3/31/2015)... 31, 2015  Ariana Smith, a 17-year-old Taylor teen, became ... Michigan , a part of the Detroit Medical Center ... to benefit from a revolutionary 3D printed heart model to ... aneurysm. In November, 2014, Ariana,s mom ... an electrocardiogram (EKG), a test that checks for problems with ...
(Date:3/31/2015)... March 31, 2015   Halyard Health (NYSE: ... it was awarded a new purchasing agreement with ... Effective March 1, 2015, Halyard,s standard and ASTM-rated ... lining, will be available to HealthTrust members made up ... ambulatory surgery centers, physician practices and alternate care facilities. ...
Breaking Medicine Technology:Medicare Advantage Enrollment Reaches 17 Million According to Mark Farrah Associates 2Taylor Teen Becomes First Patient in Michigan to Benefit From 3D Printed Heart Model to Treat Life-Threatening Aneurysm 2Taylor Teen Becomes First Patient in Michigan to Benefit From 3D Printed Heart Model to Treat Life-Threatening Aneurysm 3Taylor Teen Becomes First Patient in Michigan to Benefit From 3D Printed Heart Model to Treat Life-Threatening Aneurysm 4Taylor Teen Becomes First Patient in Michigan to Benefit From 3D Printed Heart Model to Treat Life-Threatening Aneurysm 5Halyard Health Signs First GPO Contracts As Independent Company 2Halyard Health Signs First GPO Contracts As Independent Company 3
... 2011 The National Education Association Health Information Network (NEA ... create new educational resources for middle school teachers focusing on ... The materials are currently in production, and will be released ... Assembly in Washington, D.C. They will be available in hard ...
... Claret Medical, Inc. announced today that its Montage System ... complete system of filtration to protect both carotid arteries ... brachial access, providing complete neuro protection during intravascular procedures ... design of the Montage System provides for not only ...
Cached Medicine Technology:NEA Health Information Network and Purdue Pharma L.P. Partner to Help Kids be Safe 2Claret Medical Announces CE Mark of a New Embolic Protection System to Address Stroke During Transcatheter Aortic Valve Intervention 2
(Date:3/31/2015)... Dr. Russell Ashinoff is a plastic and reconstructive ... recently quoted in an Asbury Park Press article about Lymphedema. ... retention and tissue swelling. Dr. Ashinoff is one of ... improve lymphedema symptoms. , “The goal of our ... lymphedema. The goal is to improve the intrinsic drainage ...
(Date:3/31/2015)... March 31, 2015 Dr. Uzma Parvez is ... 19th, Dr. Parvez conducted Grand Grounds Presentations at St. Michael’s ... and Managing Side Effects”. The event was attended by ... She received very positive feedback from the Grand Rounds. ... that they’ve had in a while. , Ahead, Dr. ...
(Date:3/31/2015)... 31, 2015 One of the most beautiful and ... to Mount Kilauea on the big island. The big island ... you can see molten lava slowly oozing at your feet in ... , One place you would never expect to see a ... terrain of Mission, Texas -- until now. , Members of a ...
(Date:3/31/2015)... 31, 2015 BESLER Consulting today ... “The Value of an Independent Cost Report Review.” ... a critical role in the determination of Medicare ... appropriate understanding and review, this report can assist ... planning. , This white paper discusses:, ...
(Date:3/31/2015)... Array Health , a leading provider ... Lance Hood, Senior Director of Marketing, will present at ... April 1, 2015. The session, co-presented with Brian Ridder, ... employers can streamline and simplify the private exchange shopping, ... Employee and Employer Needs in a Private Exchange – ...
Breaking Medicine News(10 mins):Health News:The Physicians at Plastic Surgery Center Each Have Something to Celebrate This March 2Health News:The Physicians at Plastic Surgery Center Each Have Something to Celebrate This March 3Health News:The Physicians at Plastic Surgery Center Each Have Something to Celebrate This March 4Health News:NJ Top Docs Presents, Dr. Uzma Parvez of Total Pain Care 2Health News:Rare Volcano Constructed inside Gold’s Gym in Mission, Texas 2Health News:Rare Volcano Constructed inside Gold’s Gym in Mission, Texas 3Health News:Array Health’s Senior Director of Marketing to Co-Present with Benaissance at The Institute for HealthCare Consumerism Private Exchange Forum 2
... 50 percent membership ... growth since 2007, INDIANAPOLIS, May 30 ... managed health care plan -- surpassing the 300,000 mark in,membership., In ... also grown its employee base by 182 percent -- going from just,over ...
... Creating an effective launch,team is imperative to ... product,s promotion relies heavily on the success of ... they create effective, cross-functional,teams that ultimately drive sales ... The detailed report provides executives with insights into ...
... of District,1199C of the National Union of Hospital ... a four-year contract agreement with,Hahnemann University Hospital that ... benefits., District 1199C represents some 1,300 workers ... hospital following some 16 and a half hours,of ...
... The science looks hopeful, but it,s still too early ... FRIDAY, May 30 (HealthDay News) -- An antioxidant found ... amyloid fibrils, a toxic protein associated with Alzheimer,s and ... is commonly seen in the brains of Alzheimer,s patients ...
... Jersey Cases, WHITEHOUSE STATION, N.J., May 30 Merck ... Texas appeals court,overturned the August 2005 verdict of a state ... of Merck in the VIOXX product liability,case Ernst v. Merck. ... after the,Company voluntarily removed the medicine from the market., ...
... maternal and child health, and effective prevention of,AIDS and ... 40 heads of State agreed today., These health ... close of a three-day summit here hosted by Japan. ... Under the theme, "Towards a vibrant Africa: A ...
Cached Medicine News:Health News:MDwise Enrollment Exceeds 300,000 Members 2Health News:Managing Cross-Functional Teams for Pharmaceutical Product Commercialization Excellence 2Health News:Green Tea Antioxidant May Help Prevent Alzheimer's 2Health News:Green Tea Antioxidant May Help Prevent Alzheimer's 3Health News:Merck Wins Appeal of First VIOXX(R) Case to go to Trial 2Health News:Merck Wins Appeal of First VIOXX(R) Case to go to Trial 3Health News:Stronger Health Systems and Better Maternal Health Critical to African Development, Japan Summit Affirms 2Health News:Stronger Health Systems and Better Maternal Health Critical to African Development, Japan Summit Affirms 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: